[Other] High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

willowwung Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-25 15:29
Reward10points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list